Over the past six years, these brands of drugs have been shipped to more than 100 countries in every populated continent on ...

U.S. health secretary Robert F. Kennedy Jr. met with major health insurers on Monday, extracting pledges that they will take ...

A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster ...

The Richmond-area partnership that’s been working since 2020 to revolutionize U.S. drug making has reached another milestone with the opening of a new lab space in the city.

U.S. Rep. Mark Green, R-Tennessee, has announced he will resign from the 7th Congressional District to pursue an "exciting" opportunity in the private sector. Green made the announcement June 9.

U.S. Rep. Mark Green, R-Tennessee, has announced he will resign from the 7th Congressional District to pursue an "exciting" opportunity in the private sector. Green made the announcement June 9.

U.S. Rep. Mark Green, R-Tennessee, has announced he will resign from the 7th Congressional District to pursue an "exciting" opportunity in the private sector. Green made the announcement June 9.

U.S. Rep. Mark Green, R-Tennessee, has announced he will resign from the 7th Congressional District to pursue an "exciting" opportunity in the private sector. Green made the announcement June 9.

The commission noted that the fixed dose combination drug is showing serious adverse reaction in the form of leukopenia, a life-threatening condition which lowers the white blood cell count.